Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9451 - 9475 of 9843 in total
Experimental
Experimental
VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).
Investigational
Matched Categories: … Membrane Lipids …
Telatinib is under investigation in clinical trial NCT03817411 (Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer).
Investigational
Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Experimental
Experimental
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Amibegron is an agonist for atypical beta3-adrenoceptors which inhibits intestinal motility.
Investigational
Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod. It has been shown to reduce disease activity on magnetic resonance imaging and to be well...
Investigational
JNJ-27390467 is a potent, nonpeptide inhibitor of human mast cell tryptase.
Experimental
Displaying drugs 9451 - 9475 of 9843 in total